Skip to content
lifestyle.phenomena.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AbbVie
BOTOX® Cosmetic (onabotulinumtoxinA) Introduces The Confidence Collective’s Entrepreneur Class of 2026
June 24, 2026
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patients
June 23, 2026
AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection
June 23, 2026
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
June 23, 2026
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
June 22, 2026
AbbVie Declares Quarterly Dividend
June 18, 2026
AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
May 29, 2026